Medicinal effect and its JP2/RyR2-based mechanism of Smilax glabra flavonoids on angiotensin II-induced hypertrophy model of cardiomyocytes

被引:17
作者
Cai, Yueqin [1 ]
Tu, Jue [1 ]
Pan, Shuizhen [2 ]
Jiang, Jianping [1 ]
Shou, Qiyang [1 ]
Ling, Yun [1 ]
Chen, Yunxiang [2 ]
Wang, Dejun [1 ]
Yang, Weiji [1 ]
Shan, Letian [1 ]
Chen, Minli [1 ]
机构
[1] Zhejiang Chinese Med Univ, Hangzhou 310053, Zhejiang, Peoples R China
[2] Zhejiang Acad Med Sci, Hangzhou 310007, Zhejiang, Peoples R China
基金
美国国家科学基金会;
关键词
Smilax glabra; Flavonoids; Cardiac hypertrophy; JP2; RyR2; RECEPTOR-TYPE; 2; CARDIAC-HYPERTROPHY; HEART-FAILURE; JUNCTOPHILIN-2; CARDIOMYOPATHY; PATHWAY; CHANNEL;
D O I
10.1016/j.jep.2015.04.026
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Rhizome and root of Smilax glabra Roxb (Liliaceae family) is a widely used traditional Chinese medicine (TCM) named Tu-fu-ling (TFL) for cardiac disease therapy. The TFL flavonoids (TFLF) has been extracted and proven to possess the anti-cardiac hypertrophy effect in our previous reports. Such effect could be mediated by the modulation of intracellular Ca2+ flux in myocardial cells, in which junctophilin-2 (JP2) and ryanodine receptor 2 (RyR2) play an important role. However, its mechanism of the anti-cardiac hypertrophy effect remains unclarified. Materials and methods: 2 mu mol/L Ang II was applied to induce hypertrophy model of rat primary cardiomyocytes. After treatment of TFLF at 025, 0.5 and 1.0 mg/ml, the cell size was microscopic measured, and the protein and mRNA expressions of JP2 and RyR2 in cardiomyocytes were estimated by immunofluorescence imaging, ELISA and real-time PCR assay. Results: Obvious hypertrophy of cardiomyocytes was induced by Ang II but reversed by TFLF from 0.5 to 1.0 mg/ml. The protein and mRNA expressions of JP2 and RyR2 in cardiomyocytes were also inhibited by Ang II but restored by TFLF at its dose range. Such effect of TFLF was exerted at a dose dependent manner, which was even better than that of verapamil. Conclusions: Our findings may evidence the correlation between JP2/RyR2 and myocardiac hypertrophy, and indicate the JP2/RyR2-mediated anti-hypertrophy mechanism of TFLF for the first time. It deserves to be developed as a promising TCM candidate of new drug for myocardial hypertrophy treatment. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:435 / 440
页数:6
相关论文
共 22 条
[1]  
[Anonymous], 1955, PHARM ZENTRALHALLE D
[2]   Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced β-myosin heavy chain gene expression and cardiomyocyte hypertrophy [J].
Cheng, TH ;
Shih, NL ;
Chen, CH ;
Lin, H ;
Liu, JC ;
Chao, HH ;
Liou, JY ;
Chen, YL ;
Tsai, HW ;
Chen, YS ;
Cheng, CF ;
Chen, JJ .
JOURNAL OF BIOMEDICAL SCIENCE, 2005, 12 (01) :123-133
[3]   Follistatin-Like 1 in Chronic Systolic Heart Failure A Marker of Left Ventricular Remodeling [J].
El-Armouche, Ali ;
Ouchi, Noriyuki ;
Tanaka, Komei ;
Doros, Gheorghe ;
Wittkoepper, Katrin ;
Schulze, Thomas ;
Eschenhagen, Thomas ;
Walsh, Kenneth ;
Sam, Flora .
CIRCULATION-HEART FAILURE, 2011, 4 (05) :621-627
[4]   Emerging role of junctophilin-2 as a regulator of calcium handling in the heart [J].
Garbino, Alejandro ;
Wehrens, Xander H. T. .
ACTA PHARMACOLOGICA SINICA, 2010, 31 (09) :1019-1021
[5]   Overexpression of junctophilin-2 does not enhance baseline function but attenuates heart failure development after cardiac stress [J].
Guo, Ang ;
Zhang, Xiaoying ;
Iyer, Venkat Ramesh ;
Chen, Biyi ;
Zhang, Caimei ;
Kutschke, William J. ;
Weiss, Robert M. ;
Franzini-Armstrong, Clara ;
Song, Long-Sheng .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (33) :12240-12245
[6]   Inhibitory effect of ginsenoside Rb1 on calcineurin signal pathway in cardiomyocyte hypertrophy induced by prostaglandin F2α [J].
Jiang, Qing-song ;
Huang, Xie-nan ;
Yang, Gui-zhong ;
Jiang, Xiao-yan ;
Zhou, Qi-xin .
ACTA PHARMACOLOGICA SINICA, 2007, 28 (08) :1149-1154
[7]   Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans [J].
Landstrom, Andrew P. ;
Weisleder, Noah ;
Batalden, Karin B. ;
Bos, J. Martijn ;
Tester, David J. ;
Ommen, Steve R. ;
Wehrens, Xander H. T. ;
Claycomb, William C. ;
Ko, Jae-Kyun ;
Hwang, Moonsun ;
Pan, Zui ;
Ma, Jianjie ;
Ackerman, Michael J. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 (06) :1026-1035
[8]   Junctophilin-2 Expression Silencing Causes Cardiocyte Hypertrophy and Abnormal Intracellular Calcium-Handling [J].
Landstrom, Andrew P. ;
Kellen, Cherisse A. ;
Dixit, Sayali S. ;
van Oort, Ralph J. ;
Garbino, Alejandro ;
Weisleder, Noah ;
Ma, Jianjie ;
Wehrens, Xander H. T. ;
Ackerman, Michael J. .
CIRCULATION-HEART FAILURE, 2011, 4 (02) :214-223
[9]  
Liang YY, 2008, CIRCULATION, V118, pS483
[10]   Inhibitory effect of trilinolein on angiotensin II-induced cardiomyocyte hypertrophy [J].
Liu, JC ;
Cheng, TH ;
Lee, HM ;
Lee, WS ;
Shih, NL ;
Chen, YL ;
Chen, JJ ;
Chan, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 484 (01) :1-8